US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.420
  • -0.180-3.21%
Close Jun 14 16:00 ET
  • 5.420
  • 0.0000.00%
Post 17:10 ET
455.09MMarket Cap-1888P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

5.70M

+305.63%
EPS(YoY)

-0.59

+29.76%
Analyst Rating

Strong Buy

May 31, 2024

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.256M--
--2024/Q2-- / 2.711M--
--2024/Q15.695M / 2.250M--
--2023/Q45.143M / 1.167M--
--2023/Q33.117M / 1.084M--
--2023/Q22.093M / 672.670K--
May 15, 20232023/Q11.404M / 514.290K--
--2022/Q41.012M / 442.860K--
--2022/Q3929.000K / 833.330K--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.256M--
--2024/Q2-- / 2.711M--
--2024/Q15.695M / 2.250M--
--2023/Q45.143M / 1.167M--
--2023/Q33.117M / 1.084M--
--2023/Q22.093M / 672.670K--
May 15, 20232023/Q11.404M / 514.290K--
--2022/Q41.012M / 442.860K--
--2022/Q3929.000K / 833.330K--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Verve Therapeutics Earnings Reports

  • Verve Therapeutics | 10-Q: Quarterly report

    May 8 07:33 ET

  • Verve Therapeutics | 10-K: Annual report

    Feb 27 08:05 ET

  • Verve Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 07:30 ET

  • Verve Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 07:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg